Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.

TitleFollicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
Publication TypeJournal Article
Year of Publication2005
AuthorsManazza AD, Bonello L, Pagano M, Chiusa L, Novero D, Stacchini A, Martini G, Vitolo U, Tarella C, Inghirami G, Palestro G, Chiarle R
JournalAm J Clin Pathol
Volume124
Issue2
Pagination182-90
Date Published2005 Aug
ISSN0002-9173
KeywordsAged, Biomarkers, Tumor, CD5 Antigens, DNA Mutational Analysis, Female, Gene Rearrangement, B-Lymphocyte, Heavy Chain, Humans, Immunohistochemistry, Immunophenotyping, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Prognosis
Abstract

Most follicular lymphomas (FLs) have a phenotype consistent with the origin from CD5-, CD10+, bcl-6+ follicular center cells and can progress to diffuse large B-cell lymphoma (DLBCL). CD5 is expressed in about 10% of DLBCLs, showing prognostic value, whereas expression is rare in FL. We present 6 cases with coexisting features of CD5+ FL and CD5+ DLBCL, supporting a follicular origin for some CD5+ DLBCLs. The follicular areas showed a meshwork of CD21+ follicular dendritic cells that were lacking in the DLBCL areas. All cases showed a clonal CD19+, CD20+, CD5+, and CD10+ population in both follicular and diffuse areas. Molecularly, 4 of 6 cases demonstrated immunoglobulin heavy chain rearrangements and 1 case, a bcl-2/immunoglobulin heavy chain gene rearrangement. Somatic hypermutations were high in all 4 cases, in keeping with their germinal center origin. Four of five patients died of disease within 42 months, consistent with the proposed prognostic value of CD5 expression in DLBCL. Our data describe an aggressive variant of CD5+ FL suggesting the follicular origin of some CD5+ DLBCLs.

DOI10.1309/8EX5-B9JF-HPEK-82BU
Alternate JournalAm J Clin Pathol
PubMed ID16040287
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700